Global X S&P Biotech ETF (CURE.AX) belongs to the Health & Biotech Equities category. Below you'll find alternative ETFs from the same category, ranked by key criteria, plus funds that investors commonly compare with CURE.AX. Use the tables to find lower-cost options, better risk-adjusted returns, or a closer substitute for your current allocation.
Other ETFs from Global X
The 10 most viewed Global X ETFs shown here include GXLD.AX, BANK.AX, ROBO.AX and span 6 categories.
| Symbol | Name | Category | Risk / Return Rank | YTD Return | AUM | Inception | |
|---|---|---|---|---|---|---|---|
| Global X Gold Bullion ETF | Gold | 17 | -11.66% | — | Apr 2024 | CURE.AX vs GXLD.AX | |
| Global X Australian Bank Credit ETF | Corporate Bonds | 84 | 2.36% | — | Jul 2024 | CURE.AX vs BANK.AX | |
| Global X ROBO Global Robotics & Automation ETF | Global Equities | 40 | 10.71% | — | Sep 2017 | CURE.AX vs ROBO.AX | |
| Global X India Nifty 50 ETF | Global Equities | 1 | -16.20% | — | Jun 2019 | CURE.AX vs NDIA.AX | |
| Global X Semiconductor ETF | Global Equities | 95 | 73.20% | — | Aug 2021 | CURE.AX vs SEMI.AX | |
| Global X Morningstar Global Technology ETF | Technology Equities | 18 | 13.34% | — | Apr 2017 | CURE.AX vs TECH.AX | |
| Global X Battery Tech & Lithium ETF | Alternative Energy Equities | 66 | 5.57% | — | Aug 2018 | CURE.AX vs ACDC.AX | |
| Global X EURO STOXX 50 ETF | Global Equities | 21 | 3.22% | — | Jul 2016 | CURE.AX vs ESTX.AX | |
| Global X S&P/ASX 200 High Dividend ETF | Dividend | 57 | 7.50% | — | Jun 2015 | CURE.AX vs ZYAU.AX | |
| Global X S&P 500 High Yield Low Volatility ETF | Global Equities | 16 | 5.46% | — | Jun 2015 | CURE.AX vs ZYUS.AX |
Compare CURE.AX with Any Fund or Stock
Compare CURE.AX with any ETF, mutual fund, or stock using PortfoliosLab's comparison tool.
Pair CURE.AX with funds that move differently
Global X S&P Biotech ETF alternatives help with substitution. Diversifiers are the next step when you want funds with lower historical correlation to CURE.AX.
Explore CURE.AX Diversifiers